Home > PB Ratio > NATCO PHARMA

NATCO PHARMA
PB (Price/Book ) Ratio

The Current P/B Ratio of NATCO PHARMA is 3.76.

Share Price ₹1,022.1Apr 23,2024
Market Cap ₹18,304.9 Cr
Book Value₹4,873.8 CrMar2023 - Consolidated Results
Price/Book 3.76xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of NATCO PHARMA

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of NATCO PHARMA is calculated as :

Current Market Cap [ ₹18,304.9 Cr] as on Apr 23,2024

(/) Book Value [ ₹4,873.8 Cr] based on Mar2023 - Consolidated Results

(=) P/B Ratio [ 3.76x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for NATCO PHARMA , the investors are currently willing to pay '3.76 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of NATCO PHARMA !

The chart below summarizes the trend in P/B Ratio of NATCO PHARMA over the last five years.

Historical PB (Price/Book ) ratio chart of NATCO PHARMA


PB Ratio Performance Analysis for NATCO PHARMA

- NATCO PHARMA 's latest p/b ratio is 3.76x.

- NATCO PHARMA 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 2.90x.

- NATCO PHARMA 's operated at median p/b ratio of 3.02x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, NATCO PHARMA 's p/b ratio peaked in Mar2021 at 3.67x.

- NATCO PHARMA 's p/b ratio hit its five-year low in Mar2023 of 2.11x.


How does NATCO PHARMA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
NATCO PHARMA 4,873.803.7618,304.9
SUN PHARMACEUTICAL INDUSTRIES LTD55,995.406.36356,001.0
CIPLA LTD23,346.004.66108,813.0
DR REDDYS LABORATORIES LTD23,140.404.2999,325.3
ZYDUS LIFESCIENCES LTD17,515.805.5196,553.2
DIVIS LABORATORIES LTD12,767.107.84100,075.0
MANKIND PHARMA LTD7,435.1612.9095,896.9
TORRENT PHARMACEUTICALS LTD6,198.0714.4089,224.4
LUPIN LTD12,315.605.8572,033.6
AUROBINDO PHARMA LTD26,839.802.3964,043.1
ABBOTT INDIA LTD3,146.0217.3954,704.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs NATCO PHARMA 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.39x
Max industry PB 17.39x
Median industry PB 5.85x
Average industry PB 7.76x



You may also like the below Video Courses